Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium pretreatment plus standard-dose rocuronium versus succinylcholine for rapid sequence induction
PACTR202505737292910Phase 3Recruiting
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Not applicable comparing Magnesium pretreatment + rocuronium bromide with Saline + succinylcholine (2 arms). Primary endpoints: Excellent intubating conditions, Ease of laryngoscopy and 2 more. Started Apr 2025; status: recruiting.
02
Drugs
magnesium sulfaterocuroniumsuccinylcholine
03
Conditions
Not applicable
Beyond the preview
Go deeper on PACTR202505737292910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505737292910.